Healthcare Services

Glioma Treatment Market Outlook 2026–2035 Driven by Key Growth Factors and Industry Projections

April 1, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Glioma Treatment Market Over The Period 2026–2030?

The glioma treatment market has experienced robust expansion in recent years. Projections indicate this market will grow from $5.37 billion in 2025 to $5.72 billion in 2026, at a compound annual growth rate (CAGR) of 6.4%. The historical growth can be attributed to advancements in neurosurgery, the development of radiation oncology, increased chemotherapy adoption, improved diagnostic imaging, and the expansion of cancer care facilities.

The market for glioma treatments anticipates significant expansion in the coming years. This sector is projected to reach $7.44 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this growth during the projected timeframe include precision oncology integration, development of novel targeted drugs, improved survival outcome focus, expansion of specialty oncology clinics, and personalized treatment protocols. Key trends anticipated within this period involve increased use of combination therapy approaches, rising focus on early surgical intervention, expansion of targeted drug therapies, growing role of radiation therapy optimization, and improved long-term disease management.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10689&type=smp

Which Major Factors Are Driving The Expansion Of The Glioma Treatment Market?

The glioma treatment market is anticipated to expand propelled by the rising demand for personalized medicine. This healthcare strategy customizes care based on individual patient attributes like genetics, environment, and lifestyle, thereby enhancing treatment efficacy and outcomes. Several elements contribute to the increasing adoption of personalized medicine, including breakthroughs in genomics, greater patient empowerment, and improved treatment effectiveness. Identifying biomarkers associated with gliomas aids in predicting treatment responses and outcomes, facilitating the creation of bespoke treatment plans tailored to each patient’s specific profile. For instance, in February 2024, the Personalized Medicine Coalition, a US-based non-profit organization, stated that the FDA approved 16 novel personalized therapies for patients with rare diseases in 2023, a significant rise from six in 2022. This increasing emphasis on personalized medicine is consequently a primary factor driving the growth of the glioma treatment market.

How Is The Glioma Treatment Market Divided Into Its Major Segments?

The glioma treatment market covered in this report is segmented –

1) By Type: Low-Grade, High-Grade

2) By Disease: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Other Diseases

3) By Route Of Administration: Oral, Parenteral, Other Routes

4) By Treatment: Surgery, Radiation Therapy, Chemotherapy, Targeted Drug Therapy, Other Treatments

5) By End-User: Hospitals, Specialty Clinics, Other End Users

Subsegments:

1) By Low-Grade: Astrocytoma, Oligodendroglioma, Mixed Glioma

2) By High-Grade: Glioblastoma Multiforme, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma

What Industry Trends Are Redefining The Glioma Treatment Market?

Leading companies in the glioma treatment market are adopting novel and innovative products, such as immunotherapies, to enhance patient outcomes and more effectively target tumors. Immunotherapies are treatments designed to stimulate or harness the body’s immune system to recognize and attack cancer cells. For instance, in June 2024, Servier Pharmaceuticals, a France-based pharmaceutical company, obtained FDA approval for VORANIGO (vorasidenib) tablets, marking a significant achievement as the first targeted therapy for Grade 2 IDH-mutant glioma. Vorasidenib acts as a dual inhibitor targeting isocitrate dehydrogenase (IDH) 1 and 2 mutations, which are frequently observed in gliomas. These mutations lead to the production of 2-hydroxyglutarate (2-HG), a metabolite that promotes tumor growth and survival. By inhibiting these enzymes, vorasidenib reduces 2-HG levels, thereby potentially slowing tumor progression.

Who Are The Prominent Organizations Shaping The Glioma Treatment Market?

Major companies operating in the glioma treatment market are Merck & Co Inc., Amgen Inc., F Hoffmann-La Roche AG, Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Arbor Pharmaceuticals LLC, Amneal Pharmaceuticals Inc., Karyopharm Therapeutics Inc., Bristol-Myers Squibb Co., Rigel Pharmaceuticals Inc., Sumitomo Dainippon Pharma Oncology Inc., Emcure Pharmaceuticals Ltd., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Sanofi S.A., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, GlaxoSmithKline plc, Bayer AG, Gilead Sciences Inc., Ipsen Pharma, Eisai Co. Ltd., Genentech Inc., Iovance Biotherapeutics Inc., Agios Pharmaceuticals Inc.

Read the full glioma treatment market report here:

https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

Which Region Currently Holds The Largest Share Of The Glioma Treatment Market?

North America was the largest region in the glioma treatment market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global glioma treatment market report during the forecast period. The regions covered in the glioma treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Glioma Treatment Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=10689&type=smp

Browse Through More Reports Similar to the Global Glioma Treatment Market 2026, By The Business Research Company

Glioblastoma Multiforme Gbm Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/glioblastoma-multiforme-gbm-treatment-global-market-report

Glioma Treatment Global Market Report

https://www.thebusinessresearchcompany.com/report/glioma-treatment-global-market-report

Adult Malignant Glioma Therapeutics Global Market Report

https://www.thebusinessresearchcompany.com/report/adult-malignant-glioma-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795